Rajiv P. Sharma - Publications

Affiliations: 
Psychiatry University of Illinois at Chicago, Chicago, IL, United States 
Area:
psychosis, epigenetics

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rosen C, McCarthy-Jones S, Chase KA, Jones N, Luther L, Melbourne JK, Sudhalkar N, Sharma RP. The role of inner speech on the association between childhood adversity and 'hearing voices'. Psychiatry Research. 286: 112866. PMID 32088506 DOI: 10.1016/j.psychres.2020.112866  1
2019 Melbourne JK, Pang Y, Park MR, Sudhalkar N, Rosen C, Sharma RP. Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages. International Immunopharmacology. 79: 106093. PMID 31863919 DOI: 10.1016/j.intimp.2019.106093  0.6
2019 Luther L, Rosen C, Cummins JS, Sharma RP. The multidimensional construct of resilience across the psychosis spectrum: Evidence of alterations in people with early and prolonged psychosis. Psychiatric Rehabilitation Journal. PMID 31750682 DOI: 10.1037/prj0000393  0.6
2019 Chase KA, Feiner B, Ramaker MJ, Hu E, Rosen C, Sharma RP. Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models. Plos One. 14: e0216463. PMID 31185023 DOI: 10.1371/journal.pone.0216463  1
2019 Feiner B, Chase KA, Melbourne JK, Rosen C, Sharma RP. Risperidone effects on heterochromatin: the role of kinase signaling. Clinical and Experimental Immunology. PMID 30714144 DOI: 10.1111/cei.13250  1
2018 Chase KA, Melbourne JK, Rosen C, McCarthy-Jones S, Jones N, Feiner BM, Sharma RP. Traumagenics: At the intersect of childhood trauma, immunity and psychosis. Psychiatry Research. 273: 369-377. PMID 30682559 DOI: 10.1016/j.psychres.2018.12.097  1
2018 Sudhalkar N, Rosen C, Melbourne JK, Park MR, Chase KA, Sharma RP. Long Non-Coding RNAs Associated with Heterochromatin Function in Immune Cells in Psychosis. Non-Coding Rna. 4. PMID 30567388 DOI: 10.3390/ncrna4040043  1
2018 Melbourne JK, Rosen C, Feiner B, Pang Y, Sharma RP. The JAK-STAT1 transcriptional signature in peripheral immune cells reveals alterations related to illness duration and acuity in psychosis. Brain, Behavior, and Immunity. PMID 30503835 DOI: 10.1016/j.bbi.2018.11.317  0.6
2018 Rosen C, McCarthy-Jones S, Chase KA, Humpston CS, Melbourne JK, Kling L, Sharma RP. The tangled roots of inner speech, voices and delusions. Psychiatry Research. 264: 281-289. PMID 29660570 DOI: 10.1016/j.psychres.2018.04.022  1
2018 Rosen C, McCarthy-Jones S, Jones N, Chase KA, Sharma RP. Negative voice-content as a full mediator of a relation between childhood adversity and distress ensuing from hearing voices. Schizophrenia Research. PMID 29580740 DOI: 10.1016/j.schres.2018.03.030  1
2018 Melbourne JK, Rosen C, Feiner B, Sharma RP. C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis. Schizophrenia Research. PMID 29449061 DOI: 10.1016/j.schres.2018.01.018  0.6
2017 Melbourne JK, Chase KA, Feiner B, Rosen C, Sharma RP. Long non-coding and endogenous retroviral RNA levels are associated with proinflammatory cytokine mRNA expression in peripheral blood cells: Implications for schizophrenia. Psychiatry Research. PMID 28942956 DOI: 10.1016/j.psychres.2017.09.025  1
2017 Melbourne JK, Feiner B, Rosen C, Sharma RP. Targeting the Immune System with Pharmacotherapy in Schizophrenia. Current Treatment Options in Psychiatry. 4: 139-151. PMID 28674674 DOI: 10.1007/s40501-017-0114-0  0.6
2017 Jenkins LM, Bodapati AS, Sharma RP, Rosen C. Working memory predicts presence of auditory verbal hallucinations in schizophrenia and bipolar disorder with psychosis. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 28562181 DOI: 10.1080/13803395.2017.1321106  0.6
2017 Rosen C, Jones N, Longden E, Chase KA, Shattell M, Melbourne JK, Keedy SK, Sharma RP. Exploring the Intersections of Trauma, Structural Adversity, and Psychosis among a Primarily African-American Sample: A Mixed-Methods Analysis. Frontiers in Psychiatry. 8: 57. PMID 28469582 DOI: 10.3389/fpsyt.2017.00057  1
2017 Bodapati AS, Jenkins LM, Sharma RP, Rosen C. Visual memory uniquely predicts anhedonia in schizophrenia but not bipolar disorder. Journal of Neuropsychology. PMID 28419772 DOI: 10.1111/jnp.12124  0.6
2017 Rosen C, Jones N, Chase KA, Melbourne JK, Grossman LS, Sharma RP. Immersion in altered experience: An investigation of the relationship between absorption and psychopathology. Consciousness and Cognition. 49: 215-226. PMID 28219788 DOI: 10.1016/j.concog.2017.01.015  1
2016 Rosen C, Jones N, Chase KA, Gin H, Grossman LS, Sharma RP. The intrasubjectivity of self, voices and delusions: A phenomenological analysis. Psychosis. 8: 357-368. PMID 27829870 DOI: 10.1080/17522439.2016.1162839  1
2016 Sharma RP, Rosen C, Melbourne JK, Feiner B, Chase KA. Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia. Neuroimmunomodulation. PMID 27820940 DOI: 10.1159/000450581  1
2016 Chase KA, Feiner B, Rosen C, Gavin DP, Sharma RP. Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia. Psychiatry Research. 245: 346-353. PMID 27591408 DOI: 10.1016/j.psychres.2016.08.055  1
2016 Gavin DP, Kusumo H, Sharma RP, Guizzetti M. Ethanol-induced changes in poly (ADP ribose) polymerase and neuronal developmental gene expression. Neuropharmacology. PMID 27497606 DOI: 10.1016/j.neuropharm.2016.08.001  1
2016 Rosen C, Chase KA, Jones N, Grossman LS, Gin H, Sharma RP. Listening to Schneiderian Voices: A Novel Phenomenological Analysis. Psychopathology. PMID 27304081 DOI: 10.1159/000446546  1
2016 Chase KA, Cone JJ, Rosen C, Sharma RP. The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia. Bmc Psychiatry. 16: 152. PMID 27206977 DOI: 10.1186/s12888-016-0866-x  1
2015 Rosen C, Jones N, Chase KA, Grossman LS, Gin H, Sharma RP. Self, Voices and Embodiment: A Phenomenological Analysis. Journal of Schizophrenia Research. 2. PMID 27099869  1
2015 Sharma RP, Feiner B, Chase KA. Histone H3 phosphorylation is upregulated in PBMCs of schizophrenia patients in comparison to healthy controls. Schizophrenia Research. PMID 26476617 DOI: 10.1016/j.schres.2015.09.030  1
2015 Gavin DP, Kusumo H, Sharma RP, Guizzetti M, Guidotti A, Pandey SC. Gadd45b and N-methyl-D-aspartate induced DNA demethylation in postmitotic neurons. Epigenomics. 7: 567-79. PMID 26111030 DOI: 10.2217/epi.15.12  1
2015 Chase KA, Rosen C, Rubin LH, Feiner B, Bodapati AS, Gin H, Hu E, Sharma RP. Evidence of a sex-dependent restrictive epigenome in schizophrenia. Journal of Psychiatric Research. 65: 87-94. PMID 25935252 DOI: 10.1016/j.jpsychires.2015.04.005  1
2015 Chase KA, Rosen C, Gin H, Bjorkquist O, Feiner B, Marvin R, Conrin S, Sharma RP. Metabolic and inflammatory genes in schizophrenia. Psychiatry Research. 225: 208-11. PMID 25433960 DOI: 10.1016/j.psychres.2014.11.007  1
2014 Guidotti A, Auta J, Davis JM, Dong E, Gavin DP, Grayson DR, Sharma RP, Smith RC, Tueting P, Zhubi A. Toward the identification of peripheral epigenetic biomarkers of schizophrenia. Journal of Neurogenetics. 28: 41-52. PMID 24702539 DOI: 10.3109/01677063.2014.892485  1
2013 Chase K, Sharma RP. Epigenetic developmental programs and adipogenesis: implications for psychotropic induced obesity. Epigenetics : Official Journal of the Dna Methylation Society. 8: 1133-40. PMID 23959141 DOI: 10.4161/epi.26027  1
2013 Gavin DP, Chase KA, Sharma RP. Active DNA demethylation in post-mitotic neurons: a reason for optimism. Neuropharmacology. 75: 233-45. PMID 23958448 DOI: 10.1016/j.neuropharm.2013.07.036  1
2013 Chase KA, Gavin DP, Guidotti A, Sharma RP. Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia. Schizophrenia Research. 149: 15-20. PMID 23815974 DOI: 10.1016/j.schres.2013.06.021  1
2013 Chase KA, Sharma RP. Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 1129-38. PMID 23067581 DOI: 10.1017/S1461145712001101  1
2012 Sharma RP. Blood chromatin as a biosensor of the epigenetic milieu: a tool for studies in living psychiatric patients. Epigenomics. 4: 551-9. PMID 23130836 DOI: 10.2217/epi.12.46  1
2012 Sharma RP, Chase KA. Increasing neuronal 'stemness': chromatin relaxation and the expression of reprogramming genes in post-mitotic neurons. Medical Hypotheses. 78: 553-4. PMID 22326495 DOI: 10.1016/j.mehy.2011.12.018  1
2012 Sharma RP, Gavin DP, Chase KA. Heterochromatin as an incubator for pathology and treatment non-response: implication for neuropsychiatric illness. The Pharmacogenomics Journal. 12: 361-7. PMID 22249356 DOI: 10.1038/tpj.2011.64  1
2012 Gavin DP, Sharma RP, Chase KA, Matrisciano F, Dong E, Guidotti A. Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 531-42. PMID 22048458 DOI: 10.1038/npp.2011.221  1
2011 Gavin DP, Chase KA, Sharma RP. Enhancement of psychotherapy using epigenetic modulating drugs. Medical Hypotheses. 77: 121-4. PMID 21504840 DOI: 10.1016/j.mehy.2011.03.042  1
2011 Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology. 60: 1007-16. PMID 21074545 DOI: 10.1016/j.neuropharm.2010.10.021  1
2010 Sharma RP, Gavin DP, Grayson DR. CpG methylation in neurons: message, memory, or mask? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2009-20. PMID 20631690 DOI: 10.1038/npp.2010.85  1
2010 Grayson DR, Kundakovic M, Sharma RP. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Molecular Pharmacology. 77: 126-35. PMID 19917878 DOI: 10.1124/mol.109.061333  1
2010 Gavin DP, Sharma RP. Histone modifications, DNA methylation, and schizophrenia. Neuroscience and Biobehavioral Reviews. 34: 882-8. PMID 19879893 DOI: 10.1016/j.neubiorev.2009.10.010  1
2009 Gavin DP, Sharma RP. Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia. Cardiovascular Psychiatry and Neurology. 2009: 409562. PMID 20029620 DOI: 10.1155/2009/409562  1
2009 Gavin DP, Rosen C, Chase K, Grayson DR, Tun N, Sharma RP. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. Journal of Psychiatry & Neuroscience : Jpn. 34: 232-7. PMID 19448855  1
2009 Gavin DP, Kartan S, Chase K, Jayaraman S, Sharma RP. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. Journal of Psychiatric Research. 43: 870-6. PMID 19187942 DOI: 10.1016/j.jpsychires.2008.12.006  1
2008 Imbesi M, Uz T, Manev R, Sharma RP, Manev H. Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors. Neuroscience Letters. 447: 134-7. PMID 18852022 DOI: 10.1016/j.neulet.2008.10.006  1
2008 Gavin DP, Kartan S, Chase K, Grayson DR, Sharma RP. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophrenia Research. 103: 330-2. PMID 18539439 DOI: 10.1016/j.schres.2008.04.026  1
2008 Sharma RP, Tun N, Grayson DR. Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures. Epigenetics : Official Journal of the Dna Methylation Society. 3: 74-80. PMID 18536530  1
2008 Sharma RP, Grayson DR, Gavin DP. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophrenia Research. 98: 111-7. PMID 17961987 DOI: 10.1016/j.schres.2007.09.020  1
2007 Rosen C, Grossman LS, Sharma RP, Bell CC, Mullner R, Dove HW. Subjective evaluations of research participation by persons with mental illness. The Journal of Nervous and Mental Disease. 195: 430-5. PMID 17502809 DOI: 10.1097/01.nmd.0000253785.81700.7d  1
2007 Imbesi M, Zavoreo I, Uz T, Sharma RP, Dimitrijevic N, Manev H, Manev R. 5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivo. Brain Research. 1147: 148-53. PMID 17349982 DOI: 10.1016/j.brainres.2007.02.012  1
2006 Sharma RP, Rosen C, Kartan S, Guidotti A, Costa E, Grayson DR, Chase K. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophrenia Research. 88: 227-31. PMID 16996718 DOI: 10.1016/j.schres.2006.07.015  1
2006 Grayson DR, Chen Y, Costa E, Dong E, Guidotti A, Kundakovic M, Sharma RP. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacology & Therapeutics. 111: 272-86. PMID 16574235 DOI: 10.1016/j.pharmthera.2005.01.007  1
2005 Sharma RP, Grayson DR, Guidotti A, Costa E. Chromatin, DNA methylation and neuron gene regulation--the purpose of the package. Journal of Psychiatry & Neuroscience : Jpn. 30: 257-63. PMID 16049569  1
2005 Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, Costa E. Reelin promoter hypermethylation in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 102: 9341-6. PMID 15961543 DOI: 10.1073/pnas.0503736102  1
2005 Noh JS, Sharma RP, Veldic M, Salvacion AA, Jia X, Chen Y, Costa E, Guidotti A, Grayson DR. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America. 102: 1749-54. PMID 15671176 DOI: 10.1073/pnas.0409648102  1
2005 Sharma RP. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophrenia Research. 72: 79-90. PMID 15560954 DOI: 10.1016/j.schres.2004.03.001  1
2003 Martis B, Alam D, Dowd SM, Hill SK, Sharma RP, Rosen C, Pliskin N, Martin E, Carson V, Janicak PG. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 114: 1125-32. PMID 12804681 DOI: 10.1016/S1388-2457(03)00046-4  1
2002 Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Research. 30: 2930-9. PMID 12087179  1
2001 Sharma RP, Martis B, Rosen C, Jonalagadda J, Nemeroff CB, Bissette G. CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders. Journal of Psychiatric Research. 35: 287-91. PMID 11591431 DOI: 10.1016/S0022-3956(01)00033-4  1
2001 Janicak PG, Keck PE, Davis JM, Kasckow JW, Tugrul K, Dowd SM, Strong J, Sharma RP, Strakowski SM. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder. Journal of Clinical Psychopharmacology. 21: 360-8. PMID 11476119  0.52
2001 Sharma RP, Martis B, Davis JM, Omens R, Janicak PG. Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis. Journal of Clinical Psychopharmacology. 21: 347-9. PMID 11386503  0.52
1998 Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 95: 15718-23. PMID 9861036 DOI: 10.1073/pnas.95.26.15718  1
1998 Sharma RP, Javaid JI, Davis JM, Janicak PG. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period. Biological Psychiatry. 44: 488-92. PMID 9777181  0.52
1998 Janicak PG, Sharma RP, Pandey G, Davis JM. Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. The American Journal of Psychiatry. 155: 972-3. PMID 9659868  0.52
1997 Sharma RP, Janicak PG, Bissette G, Nemeroff CB. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder. The American Journal of Psychiatry. 154: 1019-21. PMID 9210757  1
1997 Janicak PG, Javaid JI, Sharma RP, Leach A, Dowd S, Davis JM. A two-phase, double-blind randomized study of three haloperidol plasma levels for acute psychosis with reassignment of initial non-responders. Acta Psychiatrica Scandinavica. 95: 343-50. PMID 9150830  0.52
1997 Sharma RP, Shapiro LE, Kamath SK, Soll EA, Watanabe MD, Davis JM. Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms. Neuropsychobiology. 35: 5-10. PMID 9018017  1
1996 Javaid JI, Janicak PG, Sharma RP, Leach AM, Davis JM, Wang Z. Prediction of haloperidol steady-state levels in plasma after a single test dose. Journal of Clinical Psychopharmacology. 16: 45-50. PMID 8834418 DOI: 10.1097/00004714-199602000-00008  0.52
1996 Sharma RP, Dowd SM, Davis JM, Janicak PG. Age of illness onset and schizophrenic symptomatology during an inpatient washout period. Schizophrenia Research. 20: 295-300. PMID 8827856  0.52
1995 Sharma RP, Bissette G, Janicak PG, Davis JM, Nemeroff CB. Elevation of CSF somatostatin concentrations in mania. The American Journal of Psychiatry. 152: 1807-9. PMID 8526251  1
1995 Pandey GN, Pandey SC, Dwivedi Y, Sharma RP, Janicak PG, Davis JM. Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. The American Journal of Psychiatry. 152: 850-5. PMID 7755113  1
1995 Sharma RP, Faull K, Javaid JI, Davis JM. Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment. Acta Psychiatrica Scandinavica. 91: 293-8. PMID 7639084  0.52
1994 Sharma RP, Bissette G, Janicak P, Davis JM, Nemeroff CB. Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment. Schizophrenia Research. 13: 173-7. PMID 7986775 DOI: 10.1016/0920-9964(94)90099-X  1
1994 Sharma RP, Javaid JI, Faull K, Davis JM, Janicak PG. CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments. Psychiatry Research. 51: 51-60. PMID 7910975  0.52
1993 Pandey SC, Sharma RP, Janicak PG, Marks RC, Davis JM, Pandey GN. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment. Psychiatry Research. 48: 57-68. PMID 8105499 DOI: 10.1016/0165-1781(93)90113-U  1
1993 Sharma RP, Javaid JI, Janicak PG, Davis JM, Faull K. Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment. Biological Psychiatry. 34: 128-34. PMID 8104508  0.52
1992 Davis JM, Janicak PG, Wang Z, Gibbons RD, Sharma RP. The efficacy of psychotropic drugs: implications for power analysis. Psychopharmacology Bulletin. 28: 151-5. PMID 1513917  0.52
1992 Pandey GN, Sharma RP, Janicak PG, Davis JM. Monoamine oxidase and cortisol response in depression and schizophrenia. Psychiatry Research. 44: 1-8. PMID 1461943  0.52
1991 Javaid JI, Janicak PG, Hedeker D, Sharma RP, Davis JM. Steady-state plasma level prediction for haloperidol from a single test dose. Psychopharmacology Bulletin. 27: 83-8. PMID 1862210  1
1991 Janicak PG, Sharma RP, Israni TH, Dowd SM, Altman E, Davis JM. Effects of unilateral-nondominant vs. bilateral ECT on memory and depression: a preliminary report. Psychopharmacology Bulletin. 27: 353-7. PMID 1775610  0.52
1991 Sharma RP, Javaid JI, Pandey GN, Janicak PG, Davis JM. Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients. Biological Psychiatry. 30: 459-66. PMID 1657221  0.52
1990 Javaid JI, Sharma RP, Janicak PG, Davis JM. Plasma HVA in psychiatric patients: longitudinal studies. Psychopharmacology Bulletin. 26: 361-5. PMID 2274637  0.52
1990 Sharma RP, Javaid JI, Pandey GN, Easton M, Davis JM. Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone. Psychiatry Research. 32: 9-17. PMID 2190251  0.52
1990 Sharma RP, Janicak PG, Javaid JI, Pandey GN, Gierl B, Davis JM. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine. The American Journal of Psychiatry. 147: 1318-21. PMID 2169208  0.52
1990 Comaty JE, Janicak PG, Rajaratnam J, Sharma RP, Baker D, Davis JM. Is maintenance antiparkinsonian treatment necessary? Psychopharmacology Bulletin. 26: 267-70. PMID 1978373  1
1989 Janicak PG, Javaid JI, Sharma RP, Comaty JE, Peterson J, Davis JM. Trifluoperazine plasma levels and clinical response. Journal of Clinical Psychopharmacology. 9: 340-6. PMID 2794098  1
1989 Janicak PG, Sharma RP, Easton M, Comaty JE, Davis JM. A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania. Psychopharmacology Bulletin. 25: 243-5. PMID 2690167  1
1989 Janicak PG, Lipinski J, Davis JM, Altman E, Sharma RP. Parenteral S-adenosyl-methionine (SAMe) in depression: literature review and preliminary data. Psychopharmacology Bulletin. 25: 238-42. PMID 2690166  0.52
Show low-probability matches.